The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IWWM-12 2024 | The early detection of IgM monoclonal gammopathies
Roman Hajek, MD, PhD, University of Ostrava, Ostrava, Czech Republic, discusses the early detection and screening of IgM monoclonal gammopathies, noting that such screenings are not economically feasible. Instead, he explains that patients may be diagnosed incidentally as they undergo healthcare services for unrelated issues. This interview took place at the 12th International Workshop on Waldenström’s Macroglobulinemia (IWWM-12) in Prague, Czech Republic.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
